SunOpta Inc. (TSE:SOY - Free Report) NASDAQ: STKL - Analysts at William Blair increased their Q3 2025 EPS estimates for shares of SunOpta in a report released on Thursday, May 8th. William Blair analyst J. Andersen now expects that the company will post earnings of $0.07 per share for the quarter, up from their prior estimate of $0.06. The consensus estimate for SunOpta's current full-year earnings is $0.07 per share. William Blair also issued estimates for SunOpta's Q4 2025 earnings at $0.12 EPS and FY2026 earnings at $0.39 EPS.
SunOpta Price Performance
Shares of SOY stock traded up C$0.58 during midday trading on Friday, reaching C$9.04. 109,603 shares of the company were exchanged, compared to its average volume of 40,901. SunOpta has a 12 month low of C$5.08 and a 12 month high of C$11.40. The company has a market cap of C$753.67 million, a P/E ratio of -41.31, a PEG ratio of 3.16 and a beta of 1.83. The company's 50 day moving average price is C$6.67 and its two-hundred day moving average price is C$9.15. The company has a debt-to-equity ratio of 252.92, a quick ratio of 0.49 and a current ratio of 1.20.
About SunOpta
(
Get Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Further Reading
Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
